VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer

• Main Authors: Jiahao Liu (Author), Yinghao Wen (Author), Zhen Liu (Author), Shu Liu (Author), Ping Xu (Author), Yan Xu (Author), Shuting Deng (Author), Shulu Hu (Author), Rongcheng Luo (Author), Jingwen Jiang (Author), Guifang Yu (Author)
• Format: Book
• Published: Elsevier, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

VPS33B is reported to be a tumor suppressor in hepatocellular carcinoma, nasopharyngeal carcinoma, colon cancer, and lung adenocarcinoma. Here, we observed that reduced VPS33B protein level was an unfavorable factor that promoted the pathogenesis of non-small cell lung cancer (NSCLC) in clinical spe...